Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of topical ZEP-3Na in mild to moderate atopic dermatitis
MOH_2019-06-06_007189Phase 2Recruiting
- Sponsor
- Shulov Innovative Science
- Start
- Nov 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ZEP-3 in atopic dermatitis (AD) (3 arms), sponsored by Shulov Innovative Science. Started Nov 2019; status: recruiting.
02
Drugs
ZEP-3
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on MOH_2019-06-06_007189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-06-06_007189.